Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 143 M145 M51 M-43 M155 M159 M 322 M Research & development —————— — Operating income 296 M203 M252 M184 M866 M583 M 1.89 B Non-Operating Income, Total 0-1 M-1 M85 M61 M-147 M -2 M Interest expense, net of interest capitalized 121 M123 M131 M166 M201 M204 M 702 M Non-Operating Income, excl. Interest Expenses -121 M-123 M-131 M-166 M-113 M-287 M -697 M Unusual income/expense 0-1 M-1 M85 M-27 M-64 M -7 M Pretax income 5.07 B5.28 B6.02 B8.63 B10.58 B14.15 B 39.38 B Equity in earnings 32 M31 M40 M40 M42 M47 M 169 M Taxes -2 M7 M11 M46 M35 M79 M 171 M Non-controlling/minority interest 0000—— — After tax other income/expense -28 M00—10 M7 M — Net income before discontinued operations 207 M86 M133 M101 M644 M283 M 1.16 B Discontinued operations —————— — Net income 207 M86 M133 M101 M644 M283 M 1.16 B Dilution adjustment —00——0 — Preferred dividends 004 M——29 M — Diluted net income available to common stockholders 207 M86 M129 M101 M644 M254 M 1.13 B Basic earnings per share (Basic EPS) —————— — Diluted earnings per share (Diluted EPS) —————— — Average basic shares outstanding —————— — Diluted shares outstanding —————— — EBITDA 299 M208 M264 M236 M875 M592 M 1.97 B EBIT 296 M203 M252 M184 M866 M583 M 1.89 B Cost of revenue 4.53 B4.82 B5.39 B7.68 B9 B12.79 B 34.86 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 3 M5 M12 M52 M9 M9 M 82 M